Cargando…

Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders

The multifunctional role of the human skin is well known. It acts as a sensory and immune organ that protects the human body from harmful environmental impacts such as chemical, mechanical, and physical threats, reduces UV radiation effects, prevents moisture loss, and helps thermoregulation. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanov, Stefan R., Andonova, Velichka Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619682/
https://www.ncbi.nlm.nih.gov/pubmed/34832865
http://dx.doi.org/10.3390/ph14111083
_version_ 1784605052812394496
author Stefanov, Stefan R.
Andonova, Velichka Y.
author_facet Stefanov, Stefan R.
Andonova, Velichka Y.
author_sort Stefanov, Stefan R.
collection PubMed
description The multifunctional role of the human skin is well known. It acts as a sensory and immune organ that protects the human body from harmful environmental impacts such as chemical, mechanical, and physical threats, reduces UV radiation effects, prevents moisture loss, and helps thermoregulation. In this regard, skin disorders related to skin integrity require adequate treatment. Lipid nanoparticles (LN) are recognized as promising drug delivery systems (DDS) in treating skin disorders. Solid lipid nanoparticles (SLN) together with nanostructured lipid carriers (NLC) exhibit excellent tolerability as these are produced from physiological and biodegradable lipids. Moreover, LN applied to the skin can improve stability, drug targeting, occlusion, penetration enhancement, and increased skin hydration compared with other drug nanocarriers. Furthermore, the features of LN can be enhanced by inclusion in suitable bases such as creams, ointments, gels (i.e., hydrogel, emulgel, bigel), lotions, etc. This review focuses on recent developments in lipid nanoparticle systems and their application to treating skin diseases. We point out and consider the reasons for their creation, pay attention to their advantages and disadvantages, list the main production techniques for obtaining them, and examine the place assigned to them in solving the problems caused by skin disorders.
format Online
Article
Text
id pubmed-8619682
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86196822021-11-27 Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders Stefanov, Stefan R. Andonova, Velichka Y. Pharmaceuticals (Basel) Review The multifunctional role of the human skin is well known. It acts as a sensory and immune organ that protects the human body from harmful environmental impacts such as chemical, mechanical, and physical threats, reduces UV radiation effects, prevents moisture loss, and helps thermoregulation. In this regard, skin disorders related to skin integrity require adequate treatment. Lipid nanoparticles (LN) are recognized as promising drug delivery systems (DDS) in treating skin disorders. Solid lipid nanoparticles (SLN) together with nanostructured lipid carriers (NLC) exhibit excellent tolerability as these are produced from physiological and biodegradable lipids. Moreover, LN applied to the skin can improve stability, drug targeting, occlusion, penetration enhancement, and increased skin hydration compared with other drug nanocarriers. Furthermore, the features of LN can be enhanced by inclusion in suitable bases such as creams, ointments, gels (i.e., hydrogel, emulgel, bigel), lotions, etc. This review focuses on recent developments in lipid nanoparticle systems and their application to treating skin diseases. We point out and consider the reasons for their creation, pay attention to their advantages and disadvantages, list the main production techniques for obtaining them, and examine the place assigned to them in solving the problems caused by skin disorders. MDPI 2021-10-26 /pmc/articles/PMC8619682/ /pubmed/34832865 http://dx.doi.org/10.3390/ph14111083 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Stefanov, Stefan R.
Andonova, Velichka Y.
Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
title Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
title_full Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
title_fullStr Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
title_full_unstemmed Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
title_short Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
title_sort lipid nanoparticulate drug delivery systems: recent advances in the treatment of skin disorders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619682/
https://www.ncbi.nlm.nih.gov/pubmed/34832865
http://dx.doi.org/10.3390/ph14111083
work_keys_str_mv AT stefanovstefanr lipidnanoparticulatedrugdeliverysystemsrecentadvancesinthetreatmentofskindisorders
AT andonovavelichkay lipidnanoparticulatedrugdeliverysystemsrecentadvancesinthetreatmentofskindisorders